| 1 |
Vascular-specific growth factors and blood vessel formation
George D. Yancopoulos, Samuel H. Davis, Nicholas W. Gale et al. · Nature
|
Sep 2000 |
3,706 |
| 2 |
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G. Schwartz et al. · New England Journal of Medicine
Open access |
7 Nov 2018 |
3,654 |
| 3 |
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Peter C. Maisonpierre, Chitra Suri, Pamela F. Jones et al. · Science
|
4 Jul 1997 |
3,588 |
| 4 |
Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
Sue C. Bodine, Esther Latres, Susanne Baumhueter et al. · Science
Open access |
23 Nov 2001 |
3,550 |
| 5 |
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Jesse M. Cedarbaum, Nancy Stambler, Errol Malta et al. · Journal of the Neurological Sciences
|
Oct 1999 |
3,349 |
| 6 |
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Chitra Suri, Pamela F. Jones, Sybill Patan et al. · Cell
Open access |
Dec 1996 |
2,867 |
| 7 |
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
Sue C. Bodine, Trevor N. Stitt, Michael Gonzalez et al. · Nature Cell Biology
|
10 Oct 2001 |
2,769 |
| 8 |
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier, David M. Brown, Victor N. Chong et al. · Ophthalmology
|
17 Oct 2012 |
2,522 |
| 9 |
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson, Michel Farnier, Michel Krempf et al. · New England Journal of Medicine
Open access |
15 Mar 2015 |
2,316 |
| 10 |
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Jocelyn A. Holash, Peter C. Maisonpierre, Debra L. Compton et al. · Science
|
18 Jun 1999 |
2,209 |
| 11 |
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric Lawrence Simpson et al. · New England Journal of Medicine
Open access |
Oct 2016 |
2,101 |
| 12 |
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Uğur Şahin et al. · Nature
Open access |
30 Sep 2020 |
2,072 |
| 13 |
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Samuel H. Davis, Thomas H. Aldrich, Pamela F. Jones et al. · Cell
Open access |
Dec 1996 |
1,998 |
| 14 |
The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors
Trevor N. Stitt, Doreen Drujan, Brian A. Clarke et al. · Molecular Cell
Open access |
May 2004 |
1,972 |
| 15 |
ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
Teri G. Boulton, Steven H. Nye, David J. Robbins et al. · Cell
|
May 1991 |
1,921 |
| 16 |
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Jennifer M. Lund, Lena Alexopoulou, Ayuko Sato et al. · Proceedings of the National Academy of Sciences
Open access |
19 Mar 2004 |
1,870 |
| 17 |
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
David M. Weinreich et al. · New England Journal of Medicine
Open access |
17 Dec 2020 |
1,806 |
| 18 |
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian David Gillmore et al. · New England Journal of Medicine
Open access |
26 Jun 2021 |
1,751 |
| 19 |
Plasma proteomic associations with genetics and health in the UK Biobank
Benjamin B. Sun et al. · Nature
Open access |
4 Oct 2023 |
1,716 |
| 20 |
VEGF-Trap: A VEGF blocker with potent antitumor effects
Jocelyn A. Holash, Sam Davis, Nick Papadopoulos et al. · Proceedings of the National Academy of Sciences
Open access |
12 Aug 2002 |
1,694 |
| 21 |
Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6
Raúl Mostoslavsky et al. · Cell
Open access |
2006 |
1,649 |
| 22 |
Computationally efficient whole-genome regression for quantitative and binary traits
Joelle S. Mbatchou, Leland Barnard, Joshua Backman et al. · Nature Genetics
|
20 May 2021 |
1,637 |
| 23 |
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
Christian Rommel, Sue C. Bodine, Brian A. Clarke et al. · Nature Cell Biology
|
5 Oct 2001 |
1,587 |
| 24 |
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al. · The Lancet
|
19 Sep 2019 |
1,564 |
| 25 |
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Carolyn Hyman, Magdalena Hofer, Yves‐Alain Barde et al. · Nature
|
Mar 1991 |
1,521 |
| 26 |
Regulation of the Germinal Center Response by MicroRNA-155
To‐Ha Thai, Dinis Pedro Calado, Stefano S Casola et al. · Science
|
26 Apr 2007 |
1,486 |
| 27 |
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum, Benjamin O. Fulton, Elzbieta H Wloga et al. · Science
Open access |
15 Jun 2020 |
1,484 |
| 28 |
Molecular cloning and expression of brain-derived neurotrophic factor
Joachim Leibrock, Friedrich Lottspeich, Andreas Höhn et al. · Nature
|
Sep 1989 |
1,474 |
| 29 |
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Hellmut G. Augustin, Gou Young Koh, Gavin Thurston et al. · Nature Reviews Molecular Cell Biology
Review |
23 Feb 2009 |
1,468 |
| 30 |
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Jeremy S. Duffield, Stuart John Forbes, Christothea M. Constandinou et al. · Journal of Clinical Investigation
Open access |
3 Jan 2005 |
1,448 |
| 31 |
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna K. Hansen et al. · Science
Open access |
15 Jun 2020 |
1,436 |
| 32 |
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael Robert Migden et al. · New England Journal of Medicine
Open access |
4 Jun 2018 |
1,430 |
| 33 |
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton et al. · New England Journal of Medicine
|
9 Jul 2014 |
1,426 |
| 34 |
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Gavin Thurston, Chitra Suri, Kenneth J. Smith et al. · Science
|
24 Dec 1999 |
1,369 |
| 35 |
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Dongsheng Cai, J. Daniel Frantz, Nicholas E. Tawa et al. · Cell
Open access |
Oct 2004 |
1,369 |
| 36 |
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally E. Wenzel, Linda Ford, David S. Pearlman et al. · New England Journal of Medicine
Open access |
21 May 2013 |
1,329 |
| 37 |
Angiopoietin-1 protects the adult vasculature against plasma leakage
Gavin Thurston, John S. Rudge, Ella Ioffe et al. · Nature Medicine
|
Apr 2000 |
1,310 |
| 38 |
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al. · The Lancet
Open access |
4 May 2017 |
1,269 |
| 39 |
Neurotrophin-3: a Neurotrophic Factor Related to NGF and BDNF
Peter C. Maisonpierre, Leonardo Belluscio, Stephen P. Squinto et al. · Science
|
23 Mar 1990 |
1,255 |
| 40 |
NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
Peter C. Maisonpierre, Leonardo Belluscio, Beth Friedman et al. · Neuron
|
Oct 1990 |
1,242 |
| 41 |
Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation
David B. Lombard, Frederick W. Alt, Hwei-Ling Cheng et al. · Molecular and Cellular Biology
Open access |
9 Oct 2007 |
1,227 |
| 42 |
SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells
Marcia C. Haigis, Raúl Mostoslavsky, Kevin M. Haigis et al. · Cell
Open access |
Sep 2006 |
1,162 |
| 43 |
Mapping the human genetic architecture of COVID-19
COVID-19 Host Genetics Initiative et al. · Nature
Open access3,896 authors |
8 Jul 2021 |
1,130 |
| 44 |
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
Leonid Yurkovetskiy et al. · Cell
Open access |
15 Sep 2020 |
1,122 |
| 45 |
Skeletal muscle hypertrophy and atrophy signaling pathways
David J. Glass · The International Journal of Biochemistry & Cell Biology
|
Jun 2005 |
1,105 |
| 46 |
The power of genetic diversity in genome-wide association studies of lipids
Sarah E. Graham et al. · Nature
Open access527 authors |
9 Dec 2021 |
1,099 |
| 47 |
Exome sequencing and analysis of 454,787 UK Biobank participants
Joshua Backman et al. · Nature
Open access |
18 Oct 2021 |
1,092 |
| 48 |
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor
Alexander I. Sobolevsky, Michael P. Rosconi, Eric Gouaux · Nature
Open access |
29 Nov 2009 |
1,051 |
| 49 |
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Nicholas J. Papadopoulos, Joel H. Martin, Qin Ruan et al. · Angiogenesis
Open access |
3 Feb 2012 |
1,048 |
| 50 |
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
Ralf H. Adams, George A. Wilkinson, Chana Weiss et al. · Genes & Development
Open access |
Feb 1999 |
1,039 |